Ireland
--:--IST
Recruiting Observational

Sarcopenia in Chronic Lung Diseases

NCT06280443 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2022-11-25
Last updated
2024-04-04

Condition(s) studied

SarcopeniaCOPDAsthmaILD

Study summary

Inclusion criteria A)Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.

B) Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment. 2. Those who meet the conditions for frailty diagnosis after assessment by the Frailty Scale 3. Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources 4. Age\>=20 Exclusion Criteria: 1. Patients who refuse to sign the consent form 2. Patients who are bed ridden or unable to walk due to physical disabilities 3. Patients with terminal cancer or human acquired immunodeficiency syndrome 4. Patients with edema (pitting edema +2)

Primary outcome measure(s)

  • sarcopenia rate — 1 year
    The proportion of sarcopenia diagnosis in patients with chronic lung diseases

Trial sites (1)

FacilityCityRegionStatus
Taichung Veterans General Hospital Taichung Taiwan Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06280443 on ClinicalTrials.gov ↗ ← All trials in Taiwan